Keep Momentum on Pandemic ‘Treaty’, Urges Tedros 05/12/2022 Kerry Cullinan Keep the momentum to negotiate a pandemic instrument, urged Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) at the start of the third meeting of the intergovernmental negotiating body (INB) on Monday. “The conceptual zero-draft that your bureau has developed is a true reflection of the aspirations for a different paradigm for […] Continue reading -> Alzheimer’s Drug is Hailed Amid Safety Concerns 01/12/2022 Kerry Cullinan A candidate drug for people with early Alzheimer’s disease slowed cognitive decline by about 27% over 18 months, according to a report on a phase 3 trial published in the New England Journal of Medicine on Tuesday. Lecanemab is a monoclonal antibody that is given as an intravenous infusion every two weeks, and targets a […] Continue reading -> COP27: Diplomatic Baby Steps amid Mounting Humanitarian Crises 24/11/2022 Paula Dupraz-Dobias (SHARM EL-SHEIKH, Egypt via The New Humanitarian) – Climate justice played a central role at COP27, where the snail’s pace of progress on addressing the climate emergency once again stood in stark contrast to the realities on disaster front lines. Negotiators and policymakers emerged from the annual summit in Egypt hailing a breakthrough on so-called […] Continue reading -> What about Debt Cancellation to Help Prevent Future Pandemics? 21/11/2022 Kerry Cullinan Negotiations on a ‘pandemic treaty’ are starting in earnest within weeks as the World Health Organization (WHO) distributed the first ‘zero-sum’ conceptual draft of the agreement to member states on Friday – but one of the biggest conundrums is how to pay to mitigate the next pandemic. The COVID-19 pandemic has had a significant impact […] Continue reading -> COP27 Agrees to Create a ‘Loss and Damage’ Fund; but Falls Short on Mitigation Ambition 19/11/2022 Elaine Ruth Fletcher & Maayan Hoffman SHARM EL SHEIKH, EGYPT – In a historic first, delegates to the 27th UN Climate Conference, COP27, agreed Sunday to create a “loss and damage” fund to assist countries suffering from the impact of the climate crisis, concluding a meeting that went into two days of overdrive, with negotiations day and night. They also added […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Alzheimer’s Drug is Hailed Amid Safety Concerns 01/12/2022 Kerry Cullinan A candidate drug for people with early Alzheimer’s disease slowed cognitive decline by about 27% over 18 months, according to a report on a phase 3 trial published in the New England Journal of Medicine on Tuesday. Lecanemab is a monoclonal antibody that is given as an intravenous infusion every two weeks, and targets a […] Continue reading -> COP27: Diplomatic Baby Steps amid Mounting Humanitarian Crises 24/11/2022 Paula Dupraz-Dobias (SHARM EL-SHEIKH, Egypt via The New Humanitarian) – Climate justice played a central role at COP27, where the snail’s pace of progress on addressing the climate emergency once again stood in stark contrast to the realities on disaster front lines. Negotiators and policymakers emerged from the annual summit in Egypt hailing a breakthrough on so-called […] Continue reading -> What about Debt Cancellation to Help Prevent Future Pandemics? 21/11/2022 Kerry Cullinan Negotiations on a ‘pandemic treaty’ are starting in earnest within weeks as the World Health Organization (WHO) distributed the first ‘zero-sum’ conceptual draft of the agreement to member states on Friday – but one of the biggest conundrums is how to pay to mitigate the next pandemic. The COVID-19 pandemic has had a significant impact […] Continue reading -> COP27 Agrees to Create a ‘Loss and Damage’ Fund; but Falls Short on Mitigation Ambition 19/11/2022 Elaine Ruth Fletcher & Maayan Hoffman SHARM EL SHEIKH, EGYPT – In a historic first, delegates to the 27th UN Climate Conference, COP27, agreed Sunday to create a “loss and damage” fund to assist countries suffering from the impact of the climate crisis, concluding a meeting that went into two days of overdrive, with negotiations day and night. They also added […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COP27: Diplomatic Baby Steps amid Mounting Humanitarian Crises 24/11/2022 Paula Dupraz-Dobias (SHARM EL-SHEIKH, Egypt via The New Humanitarian) – Climate justice played a central role at COP27, where the snail’s pace of progress on addressing the climate emergency once again stood in stark contrast to the realities on disaster front lines. Negotiators and policymakers emerged from the annual summit in Egypt hailing a breakthrough on so-called […] Continue reading -> What about Debt Cancellation to Help Prevent Future Pandemics? 21/11/2022 Kerry Cullinan Negotiations on a ‘pandemic treaty’ are starting in earnest within weeks as the World Health Organization (WHO) distributed the first ‘zero-sum’ conceptual draft of the agreement to member states on Friday – but one of the biggest conundrums is how to pay to mitigate the next pandemic. The COVID-19 pandemic has had a significant impact […] Continue reading -> COP27 Agrees to Create a ‘Loss and Damage’ Fund; but Falls Short on Mitigation Ambition 19/11/2022 Elaine Ruth Fletcher & Maayan Hoffman SHARM EL SHEIKH, EGYPT – In a historic first, delegates to the 27th UN Climate Conference, COP27, agreed Sunday to create a “loss and damage” fund to assist countries suffering from the impact of the climate crisis, concluding a meeting that went into two days of overdrive, with negotiations day and night. They also added […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
What about Debt Cancellation to Help Prevent Future Pandemics? 21/11/2022 Kerry Cullinan Negotiations on a ‘pandemic treaty’ are starting in earnest within weeks as the World Health Organization (WHO) distributed the first ‘zero-sum’ conceptual draft of the agreement to member states on Friday – but one of the biggest conundrums is how to pay to mitigate the next pandemic. The COVID-19 pandemic has had a significant impact […] Continue reading -> COP27 Agrees to Create a ‘Loss and Damage’ Fund; but Falls Short on Mitigation Ambition 19/11/2022 Elaine Ruth Fletcher & Maayan Hoffman SHARM EL SHEIKH, EGYPT – In a historic first, delegates to the 27th UN Climate Conference, COP27, agreed Sunday to create a “loss and damage” fund to assist countries suffering from the impact of the climate crisis, concluding a meeting that went into two days of overdrive, with negotiations day and night. They also added […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COP27 Agrees to Create a ‘Loss and Damage’ Fund; but Falls Short on Mitigation Ambition 19/11/2022 Elaine Ruth Fletcher & Maayan Hoffman SHARM EL SHEIKH, EGYPT – In a historic first, delegates to the 27th UN Climate Conference, COP27, agreed Sunday to create a “loss and damage” fund to assist countries suffering from the impact of the climate crisis, concluding a meeting that went into two days of overdrive, with negotiations day and night. They also added […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Urges Governments to Increase Oversight on Equitable Vaccine Manufacture and Distribution 10/11/2022 Megha Kaveri The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably. The global health agency’s call to governments came as it released its annual […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy